Sign In

Council news

New CIC guide to cannabis marketing launched

A new guide to marketing and promotion in the cannabis space has been published by the Cannabis Industry Council (CIC). Entitled ‘Promoting cannabis: current rules & regulations’, the report aims to demystify the regulatory landscape around how prescription medicines and consumer CBD products can and cannot be promoted. A section of the report also assesses […]

Read More

CIC backs hemp licensing reforms

New Home Office proposals to increase the permissible THC levels in hemp seeds to “at least 0.3%” have been backed by the Cannabis Industry Council (CIC). Currently, THC levels in hemp seeds cannot exceed 0.2%. Due to increased temperatures in the UK, this can lead to stresses in the crop, causing a natural increase in […]

Read More

CIC launches crowdfunder for public awareness campaign

UPDATE: The crowdfunder page is now closed, although we are still seeking campaign donations. For more information, or to donate, please contact enquiries@cicouncil.org.uk An online crowdfunder has been launched to raise funds to kickstart a key campaign to generate awareness of prescription cannabis and cannabinoid therapy with the public. The crowdfunder, being run by the […]

Read More

CIC becomes Secretariat for Hemp/CBD Parliamentary group

The Cannabis Industry Council (CIC) has taken on the Secretariat of the All Party Parliamentary Group (APPG) for Industrial Hemp and CBD Products. The decision was formalised at the APPG’s annual general meeting, held today (13 March) in Parliament. CIC has succeeded Tenacious Labs as Secretariat, who had been in the role since the formation […]

Read More

CIC launches Platinum Membership

We are pleased to announce the launch of CIC Platinum Membership, which is aimed at larger organisations (those in the higher two fees categories). Platinum Membership includes a range of benefits, such as free exhibition space, speaking slots, exclusive events, and much more. You will also receive the benefits of Full Membership (one-year membership). CIC […]

Read More

New report on extract market

A new report entitled ‘Extracting Opportunities’ has been published by SW4 Partners, in collaboration with CIC member Lawrence Stephens and Artemis Growth Partners. The report focuses on the evolving extract-based cannabis medicines market in Europe, and combines detailed analysis with engaging content to highlight the opportunities and complexities of this sector. Download the report here. […]

Read More

New CIC Advocacy Representative

The CIC is pleased to announce that Paul North has become our new Advocacy Representative. Paul will also sit on the CIC’s Executive Committee. Paul is the Director of CIC member Volteface, a leading organisation in the cannabis industry – which both provides commercial services, and manages one of the most visited cannabis news sites […]

Read More

Cannabis flower monograph published

The new European Pharmacopoeia monograph on Cannabis flower (3028) has reportedly been officially published in Ph. Eur. Supplement 11.5, according to GMP-Compliance. The monograph had been pre-published in October 2023 on the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe website. GMP-Compliance notes a number of additional requirements have been […]

Read More

CIC signs Armed Forces Covenant

A commitment to supporting the UK’s military community and veterans – known as the Armed Forces Covenant – has been signed by the Cannabis Industry Council (CIC). The signed pledge states: “We commit to uphold the Armed Forces Covenant and support the Armed Forces Community. We recognise the contribution that Service personnel, both regular and […]

Read More

Innovative business leader Stef Kulik joins CIC Board

Highly experienced and innovative business leader Stef Kulik has joined the Board of the Cannabis Industry Council (CIC) as a Non Executive Director. Stef is currently managing director of the health division of a well-known British brand. He has previously worked in the consumer goods industry, in private equity, venture capital, and for a number […]

Read More